2024
Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke
Bernstein S, Yager J, Sigel K, Porter E, Do T, Payne E, Bold K, Ledgerwood D, Edelman E. Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke. Journal Of Addiction Medicine 2024, 18: 404-407. PMID: 38606851, PMCID: PMC11290992, DOI: 10.1097/adm.0000000000001302.Peer-Reviewed Original ResearchNicotine replacement therapyHuman immunodeficiency virusTobacco use disorderAntiretroviral therapyReplacement therapyTobacco useImmunodeficiency virusCoverage of antiretroviral therapyInsurance coverageSecondary analysis of dataUse disorderManaged care planOut-of-pocketMandated insurance coverageCare planningEfficacy of antiviralsRandomized clinical trialsPharmacy benefit managersInsurance barriersMedication prescriptionsSecondary analysisTracking formParticipation AssessmentAntiviral medicationsPWH
2015
Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit
Bold KW, McCarthy DE, Minami H, Yeh VM, Chapman GB, Waters AJ. Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit. Drug And Alcohol Dependence 2015, 158: 30-37. PMID: 26585613, PMCID: PMC4698113, DOI: 10.1016/j.drugalcdep.2015.10.024.Peer-Reviewed Original ResearchConceptsRisk factorsQuit attemptsAlcohol useSmoking cessation counselingNicotine replacement therapyRecent alcohol useCessation counselingTreatment-seeking daily smokersCigarette exposureReplacement therapyDaily smokersRelapse mechanismsSmokersSecondary analysisSmoking lapseHigh distressSmokingEcological momentary assessment dataCurrent studyDaysFactorsTherapyCombination of factors